Volume 11, Issue 1 (Vol.11 No.1 Apr 2022)
rbmb.net 2022, 11(1): 182-189 |
Back to browse issues page
Shaymaa Obaid Abdullah 
, Ghazi Mohamad Ramadan , Hayder Abdul-Amir Makki Al-Hindy * , Mazin Jaafar Mousa , Amir Al-Mumin , Safa Jihad , Suhad Hafidh , Yaqeen Kadhum
, Ghazi Mohamad Ramadan , Hayder Abdul-Amir Makki Al-Hindy * , Mazin Jaafar Mousa , Amir Al-Mumin , Safa Jihad , Suhad Hafidh , Yaqeen Kadhum
College of Pharmacy, University of Babylon, Babylon, Iraq.
Abstract: (2335 Views)
Background: The contribution of neutrophils is still indistinct in the inflammatory response of bronchial asthma (BAs). Myeloperoxidase (MPO) is an enzyme released from the primary azurophilic granules of the neutrophils. The study aimed to evaluate the levels of serum MPO as a biomarker for
the assessment of the level of asthma control.
Methods: The study participants included 94 asthmatic patients and 86 healthy controls. The identification of asthma severity had assessed using the ''Global Initiative for Asthma guidelines''. Asthmatic adults had divided into three groups: Good (n= 22), partial (n= 30), and poor control (n=44). Also, patients have been divided again into two groups (treated and untreated) for BAs.
Results: The predicted FEV1% and the peak expiratory flow (PEF/L) of all participants had verified by spirometry. The mean patients’ age was 31.9±15.1 year, with a predominance of females. The mean asthma duration was 10.5±8.6 years. Mean spirometric parameters (FEV1 and PEF) were significantly lower among the patients (0.00). Significant higher MPO levels had observed among BAs patients (p-0.00). The MPO levels have not differed significantly with asthma levels and had significant differences with the history of treatment. There was a nonsignificant negative correlation between the mean MPO levels and the spirometry variables among the patients. ROC curves revealed a sensitivity, specificity, accuracy for MPO (80.9%, 72.1%, and 84.3%), respectively to predict asthmatic severity.
Conclusions: There were significantly higher MPO levels compared to healthy controls. Levels of serum MPO had a non-significant positive correlation with levels of asthma control, but a negative non-significant correlation with spirometric results.
the assessment of the level of asthma control.
Methods: The study participants included 94 asthmatic patients and 86 healthy controls. The identification of asthma severity had assessed using the ''Global Initiative for Asthma guidelines''. Asthmatic adults had divided into three groups: Good (n= 22), partial (n= 30), and poor control (n=44). Also, patients have been divided again into two groups (treated and untreated) for BAs.
Results: The predicted FEV1% and the peak expiratory flow (PEF/L) of all participants had verified by spirometry. The mean patients’ age was 31.9±15.1 year, with a predominance of females. The mean asthma duration was 10.5±8.6 years. Mean spirometric parameters (FEV1 and PEF) were significantly lower among the patients (0.00). Significant higher MPO levels had observed among BAs patients (p-0.00). The MPO levels have not differed significantly with asthma levels and had significant differences with the history of treatment. There was a nonsignificant negative correlation between the mean MPO levels and the spirometry variables among the patients. ROC curves revealed a sensitivity, specificity, accuracy for MPO (80.9%, 72.1%, and 84.3%), respectively to predict asthmatic severity.
Conclusions: There were significantly higher MPO levels compared to healthy controls. Levels of serum MPO had a non-significant positive correlation with levels of asthma control, but a negative non-significant correlation with spirometric results.
Type of Article: Original Article |
Subject:
Immunology
Received: 2021/10/21 | Accepted: 2021/10/25 | Published: 2022/05/26
Received: 2021/10/21 | Accepted: 2021/10/25 | Published: 2022/05/26
References
1. Dharmage SC, Perret JL, Custovic A, Epidemiology of Asthma in Children and Adults. Front Pediatr, 2019;7:246. [DOI:10.3389/fped.2019.00246] [PMID] [PMCID]
2. Hayder Makki, Hemid AJ, Mazin J, Safa Jihad Hameed, Suhad Hafidh Obeed. The utility of serum IL-1β and CRP together with fractional exhaled nitric oxide in the diagnosis of asthma in adults. NeuroQuantology. 2021;19(8):119-124. [DOI:10.14704/nq.2021.19.8.NQ21122]
3. Amjed H Abbas, MA Albarqaawi, Hayder Abdul-Amir Al-Hindy, Mazin J, Hadeel Abd, Ameir Al-Shalah. The Role of Serum IL-1β in Combination with Fractional Exhaled Nitric Oxide in the Diagnosis of Adult Bronchial Asthma. NeuroQuantology. 2021;19(8):13-19. [DOI:10.14704/nq.2021.19.8.NQ21107]
4. Nadeem A, A Masood, N Siddiqui. Oxidant-antioxidant imbalance in asthma: scientific evidence, epidemiological data, and possible therapeutic options. Ther Adv Respir Dis. 2008;2(4):215-35. [DOI:10.1177/1753465808094971] [PMID]
5. QasimJ, Jawad Fadil Q, Bash H, Hamid G, High-Sensitivity C - reactive protein Assessment in Bronchial Asthma: Impact of Exhaled Nitric Oxide and Body Mass Index. Systematic Reviews in Pharmacy. 2020;11(3):705.
6. Enas K, Alkhazraji, A.A.A., Mahir Abdulkhadhum Alzughaibi, Hayder Abdul-Amir Alhindy and Mazin J. Mousa Positive correlation of circulating tumor necrosis factor-alpha (TNFα) with spirometric pulmonary tests in adult asthmatic patients. Biochemical and Cellular Archives. 21(Supplement 1):2605-2610.
7. Tauber E, H.Y., Goetz M., Urbanek R., Hagel E. & Koller D.Y., Assessment of serum myeloperoxidase in children with bronchial asthma. Allergy. 1999;54(2):177-82. [DOI:10.1034/j.1398-9995.1999.00797.x] [PMID]
8. Venge P. Soluble markers of allergic inflammation. Allergy. 1994;49(1):1-8. [DOI:10.1111/j.1398-9995.1994.tb00765.x] [PMID]
9. Kim CB, Shim DH, Kim MJ, Cha HR, Hwang SJ, Park JH et al. Increased levels of human myeloperxidase (MPO) and neutrophil lipocalin (HNL/NGAL) in childhood asthma. European Respiratory Journal. 2019;54 (Suppl 63):PA530. [DOI:10.1183/13993003.congress-2019.PA530]
10. Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non-T2 asthma. Allergy. 2020;75(2):311-325. [DOI:10.1111/all.13985] [PMID]
11. Fedor EL, Freniere VL, Ostroff J, Ostroff M. The 2019 GINA Guidelines for Asthma Treatment in Adults. US Pharm. 2020;45(7/8):18-24.
12. Asseel K, AL-Saad R, Raad J, Makki HAA. Biochemical Significance of Cystatin-C and High-Sensitive CRP in Patients with Acute Coronary Syndrome; any Clinical Correlation with Diagnosis and Ejection Fraction. Sys Rev Pharm. 2020;11(3):301-308.
13. Hajir K., F.D., Ameera Al-Aaraji, Hayder Hindy, Mazin J., Biochemical Causal-Effect of Circulatory Uric Acid, and HSCRP and their Diagnostic Correlation in Admitted Patients with Ischemic Heart Diseases. JCDR. 2020;11(2):25-30.
14. Makki H, Jaafar M, Al-kashwan TA, Sudan A, Abdul-RazzaqSA. On Admission Levels of High Sensitive C- Reactive Protein as A Biomarker in Acute Myocardial Infarction: A Case-Control Study. Indian Journal of Public Health Research & Development. 2019;10(4):1480. [DOI:10.5958/0976-5506.2019.00924.0]
15. Parco S. Leukocyte peroxidase and leptin: an associated link of glycemic tolerance and bronchial asthma?. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2010;3:113-116.
https://doi.org/10.2147/DMSO.S8504 [DOI:10.2147/DMSOTT.S8504]
16. Al-Saad RZ, A Shaker, Fouad SH, Dleikh FSH, Makki H. Is There Any Association Between Highly Sensitive C-Reactive Protein and Dental-Status in Ischemic Heart Diseases? A Comparative-Study. Biochemical and Cellular Archives. 2020;20(2):6069-6075.
17. Al-Mumin A, Makki HAA, Mous MJ. Combined Assessments of Multi-panel Biomarkers for Diagnostic Performance in Coronary Artery Disease: Case-Control Analysis. Syst Rev Pharm. 2020;11(6):665-671.
18. Makki H, Jaafar M, Majeed S, Hasan AS. C- Reactive Protein is Associated with the Severity of Periodontal Disease - An Observational Study Among Acute Myocardial Infarction Patients. Systematic Reviews in Pharmacy. 2020;12(3).
19. Makki H, Mumin SM. Hyperuricemia Has a Deleterious Role in Patients with Acute Coronary Syndrome Presented with Poor Oral Hygiene. Biomarkers of Acute myocardial infarction. 2020;193.
20. Wang H, Jia Y, Yi M, Li Y, Chen O. High Serum Uric Acid Was a Risk Factor for Incident Asthma: An Open Cohort Study. Risk management and healthcare policy. 2020;13:2337-2346. [DOI:10.2147/RMHP.S277463] [PMID] [PMCID]
21. Gorgone D, McShane L, McSharry Ch, TJ Guzik, Maffia P. Cytokines at the Interplay Between Asthma and Atherosclerosis? Front. Pharmacol. 2020. [DOI:10.3389/fphar.2020.00166] [PMID] [PMCID]
22. Bazan-Socha S, Mastalerz L, Cybulska A, Zareba L, Kremers R, Zabczyk M, et al. Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood. Inflammation. 2017;40(4):1225-1235. [DOI:10.1007/s10753-017-0565-x] [PMID] [PMCID]
23. AA Khan, MA Alsahli, Rahmani AH. Myeloperoxidase as an Active Disease Biomarker: Its Recent Biochemical and Pathological Perspectives. Med Sci (Basel). 2018;18;6(2):33. [DOI:10.3390/medsci6020033] [PMID] [PMCID]
24. Hameed R, Ewadh MJ, Saifullah PH. Evaluation of new Correlation Between Myeloperoxidase -AB and Trace Elements in Sera of Ischemic Heart disease patients. Medical Journal of Babylon. 2007; 4(3-4):205-218.
25. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1532-9. [DOI:10.1164/ajrccm.160.5.9806170] [PMID]
26. Shareef F, Dleikh F Sh, Jasim A, Al-Aaraji, Mohin R, Jaafar M. Possible cause-and-effect linkage of transforming growth factor-beta1 and platelets derived growth factor-AB with delayed anthropometric parameters in adolescent patients with Cooley's anemia: Cases vis control research strategy. EurAsian Journal of BioSciences. 2020;14(1):1119-1125.
27. Makki H, Mousa JM, Shaker AK. No Significant Relationship of Ferritin Levels to the Levels of Platelet-derived Growth Factor (PDGF) in the Peripheral Blood of Transfusion-dependent ß-Thalassemia Major Patients with Growth Retardation. Measuring some growth factors in thalassemia major. 2020;12(3):568-575. [DOI:10.31838/ijpr/2020.12.03.084]
28. Kardas G, Daszyńska-Kardas A, Marynowski M, Brząkalska O, Kuna P, Panek M. Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target. Front Pharmacol. 2020;11:47. [DOI:10.3389/fphar.2020.00047] [PMID] [PMCID]
29. Al-Hindy H, Mousa MJ, Shaker A, Al-Saad R, Al-Dujaili W. Relationship of levels of transforming growth factorbeta1 (TGF-β1) to the levels of ferritin in the blood of transfusion-dependent β-thalassemia major patients with growth retardation: A case-control study. EurAsian Journal of BioSciences. 2020;14:521-527.
30. Mousa MJ, Al-Saffar HS, Al-Hindy HAAM , Low-Level Laser (Biophotomodulation) Therapy for the Treatment of Diabetic Foot Ulcers with 532 nm KTP Laser Induces Wound Healing, Fibroblast Proliferation and Over-expression of TGF-B. Sys Rev Pharm. 2020;11(6):396-403.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |